# SpArking change for patients with psoriatic arthritis and axial spondyloarthritis in the UK: results from a UK Delphi consensus study

**Authors:** Philip S Helliwell, Antoni Chan, David Crosbie, Pauline Ho, Elena Nikiphorou, Andrew Pothecary, Raj Sengupta, Ben Thompson

PMC · DOI: 10.1093/rap/rkag005 · Rheumatology Advances in Practice · 2026-01-09

## TL;DR

UK experts agree on improving care for psoriatic arthritis and axial spondyloarthritis through patient empowerment and better access to treatment.

## Contribution

A UK-specific consensus was developed using a modified Delphi method to guide care improvements for PsA and axial SpA.

## Key findings

- 98% of 56 statements reached consensus, with 93% achieving strong consensus.
- Experts supported patient empowerment tools, shared decision-making, and timely access to biologics.
- Multidisciplinary care and personalized treatment approaches were strongly endorsed.

## Abstract

To establish a UK-specific consensus on improving standards of care for patients with PsA and axial SpA through patient empowerment, education, access and optimal treatment approaches.

A modified Delphi methodology was employed. A steering group of UK rheumatologists and pharmacists developed 56 consensus statements across four domains: patient empowerment, patient and healthcare professional (HCP) knowledge, access to healthcare and treatment principles. These statements were tested with a panel of 100 UK rheumatologists using a 4-point Likert scale. Consensus was predefined as ≥75% agreement.

Consensus was achieved for 98% (55/56) of statements; 93% (52/56) reached strong consensus (≥90%). Statements supported embedding patient empowerment tools (e.g. patient-reported outcome measures, patient activation measures), implementing patient-initiated follow-up and ensuring shared decision-making. Respondents strongly endorsed multidisciplinary care, tailored educational resources, psychological support and timely access to physiotherapy and biologics. Treatment decisions should prioritise clinical need and patient goals rather than cost alone.

This UK Delphi consensus highlights expert agreement that best practice care for PsA and axial SpA should centre on patient empowerment, supported by multidisciplinary teams, education and equitable access to treatments. Implementing personalised, holistic care models has the potential to improve patient outcomes and reduce healthcare burden. Further research should validate these recommendations with patients and explore strategies for their integration into National Health Service practice.

## Full-text entities

- **Diseases:** psoriatic arthritis (MESH:D015535), axial SpA (MESH:C537791), axial spondyloarthritis (MESH:D000089183)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12857574/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12857574/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12857574/full.md

---
Source: https://tomesphere.com/paper/PMC12857574